COEP COEPTIS THERAPEUTICS HOLDINGS INC Investments/Divestments 8-K Filing 2024 - Equity Sale and CEO Options Grant Coeptis Therapeutics Holdings, Inc. raised $4.3 million in the sale of preferred stock to accredited investors, and granted options to its CEO.Get access to all SEC 8-K filings of the COEPTIS THERAPEUTICS HOLDINGS INC